AB
ARTELO BIOSCIENCES, INC.
SEC filingBiotechnology · Solana Beach, CA
Amount raised$11Msold at filing
Total offering$11M
Investors in the raise2count reported to the SEC
FiledApr 6, 2026first sale Mar 27, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Douglas D. BlayneyDirector
R. Martin EmanueleDirector
Connie D. MatsuiDirector
Mark R. SpringExecutive Officer
Gregory R. ReyesDirector
Tamara A. FavoritoDirector
Steven D. KellyDirector
Gregory D. GorgasExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.